Published in Law and Health Weekly, May 3rd, 2008
The net proceeds from the public offering, after underwriting discounts and estimated offering expenses, to the Company will be approximately $37,340,950. The Company intends to use the net proceeds from the public offering to repay indebtedness and for other general corporate purposes, including to fund...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.